重症肌无力患者血浆置换后呼吸功能的纵向改善
该回顾性研究分析了一家三级医院4年内22例重症肌无力危象患者(27次危象发作、508次测量)在血浆置换前后的用力肺活量(FVC)和负压吸气力(NIF)。采用混合效应多重线性回归估计预测值,结果显示NIF在首次血浆置换前下降、之后平均每日增加1 cm H2O(95%CI 0.68-1.32,p<0.001),FVC在首次置换前波动、之后平均每日增加51.2 mL(95%CI 35.8-66.1,p<0.001)。NIF最大增幅出现在首次血浆置换当日(9.2 cm H2O,95%CI 3.3-15.1,p=0.002),FVC较基线的显著增加出现在首次置换后第2天(287 mL,95%CI 7.5-567.6,p=0.04)。作者认为床旁呼吸测量在首次血浆置换当日即可观察到显著改善,但FVC变异性大于NIF,可能反映FVC技术不一致或治疗对NIF效果更一致。
要点
- 重症肌无力危象患者血浆置换后NIF平均每日增加1 cm H2O(95%CI 0.68-1.32,p<0.001),FVC平均每日增加51.2 mL(95%CI 35.8-66.1,p<0.001)。
- NIF最大增幅出现在首次血浆置换当日(9.2 cm H2O,95%CI 3.3-15.1,p=0.002),第10天后增幅放缓。
- FVC较基线的显著增加出现在首次血浆置换后第2天(287 mL,95%CI 7.5-567.6,p=0.04),并持续(伴波动)增至第17天。
- 研究纳入22例患者(平均年龄67.3岁,51.9%男性)共27次危象发作,36.6%需要插管机械通气,平均血浆置换5.1次(范围3-11)。
- 作者认为FVC变异性大于NIF,可能反映FVC技术不一致或治疗对NIF效果更一致。
适用人群与场景
- 入住三级医院的重症肌无力危象患者,22例患者共27次危象发作;平均年龄67.3岁,51.9%为男性;70.4%检测到抗体。
处置流程与药物剂量
- 血浆置换隔日一次,平均5.1次(范围3-11)。
- 以首次血浆置换前一天为基线,每日多次测量取平均值,监测FVC和NIF。
研究设计与关键结果
- 回顾性分析4年内22例重症肌无力危象患者(27次发作、508次测量:234次FVC和274次NIF,覆盖血浆置换前5天至后20天)。
- NIF在首次血浆置换前下降,之后平均每日增加1 cm H2O(95%CI 0.68-1.32,p<0.001)。
- FVC在首次血浆置换前波动,之后平均每日增加51.2 mL(95%CI 35.8-66.1,p<0.001)。
- NIF最大增幅出现在首次血浆置换当日(9.2 cm H2O,95%CI 3.3-15.1,p=0.002),第10天后增幅放缓。
- FVC较基线显著增加出现在首次血浆置换后第2天(287 mL,95%CI 7.5-567.6,p=0.04),并持续(伴波动)增至第17天。
- 36.6%的患者需要插管和机械通气。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为床旁呼吸测量在首次血浆置换当日即可观察到显著改善,但FVC变异性大于NIF,可能反映FVC技术不一致或治疗对NIF效果更一致。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There are no data on the effect size and timing of plasma exchange (PLEX) in patients with myasthenic crisis (MC).
METHODS: We retrospectively analyzed measurements of forced vital capacity (FVC) and negative inspiratory force (NIF) in the days before and after PLEX (administered every other day) in patients with MC admitted to a tertiary hospital over 4 years. For multiple measurements in one day, the average value was used. The day immediately before the first treatment with PLEX was considered baseline. Using time as a continuous or categorical variable in mixed-effects multiple linear regressions, we estimated predicted values for these tests.
RESULTS: Twenty-two patients (mean age 67.3 years, 51.9% male patients) with 27 MC episodes and 508 measurements (234 FVC and 274 NIF; from 5 days before to 20 days after PLEX) were included. Presence of antibodies was detected in 70.4%. Intubation and mechanical ventilation occurred in 36.6% of patients. The mean number of PLEX was 5.1 (range 3-11). NIF values decreased before the first PLEX but increased after by on average 1 cm H2O/day (95% confidence interval [CI] 0.68-1.32, p < 0.001). FVC fluctuated before the first PLEX but then increased by on average 51.2 mL/day (95% CI 35.8-66.1, p < 0.001). The maximum increase in NIF occurred during the day of the first PLEX (9.2 cm H2O, 95% CI 3.3-15.1, p = 0.002) and rather slowed after day 10. FVC increase compared to baseline became significant the second day after the first PLEX (287 mL, 95% CI 7.5-567.6, p = 0.04) and continued overall to increase (with fluctuations) up to day 17.
CONCLUSIONS: Significant increases in bedside respiratory measurements are observed as soon as the first PLEX day but with more variability on FVC than NIF, which may either reflect more FVC technique inconsistencies or more consistent effect of the treatment on NIF.
参考来源
- Varelas PN, Lopez-Plaza I, Ata A, et al. Longitudinal Improvement in Respiratory Function Following Plasma Exchange in Patients with Severe Myasthenia Gravis. Neurocrit Care. 2025. PMID: 40180670. doi:10.1007/s12028-025-02238-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。